Lesser doses for perioral treatment than for higher facial purposes are employed given that the oral musculature responds additional strongly to a similar BTX-A dosing. Just one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. Botox® (onabotulinumtoxinA) https://jetonlinepharma.us/product-category/botulinum-toxins/